Literature Citations Close

Literature Citations for OriGene clone representing NM_004972


Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements, Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, and Nicholas C.P. Cross, Haematologica, Mar 2013; 98: 404 - 408.

A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway, Ying Zheng, Hongwei Qin, Stuart J. Frank, Luqin Deng, David W. Litchfield, Ayalew Tefferi, Animesh Pardanani, Fang-Tsyr Lin, Jingzhi Li, Bingdong Sha, and Etty N. Benveniste, Blood, Jul 2011; 118: 156 - 166.

Intramolecular Disulfide Bonds of the Prolactin Receptor Short Form Are Required for Its Inhibitory Action on the Function of the Long Form of the Receptor, Y.-L. Xie, S. A. Hassan, A. M. Qazi, C. H. Tsai-Morris, and M. L. Dufau, Mol. Cell. Biol., May 2009; 29: 2546 - 2555.

Ligand-Independent Homo- and Heterodimerization of Human Prolactin Receptor Variants: Inhibitory Action of the Short Forms by Heterodimerization, Aamer M. Qazi, Chon-Hwa Tsai-Morris, and Maria L. Dufau, Mol. Endocrinol., Aug 2006; 20: 1912 - 1923.